It is now recommended that people who have been vaccinated against COVID-19 get a vaccine booster to improve their protection from the virus. This is the most recent guidance (November 19, 2021) from the CDC on COVID-19 vaccine boosters.
Who is eligible for a COVID-19 booster shot?
People 18+ who have completed initial COVID-19 vaccination — 2 doses of Pfizer or Moderna or 1 dose of Johnson & Johnson Janssen (J&J).
When should you get it?
- At least 6 months after the initial Pfizer or Moderna series
- At least 2 months after the J&J shot
Which booster you should get?
- You can choose which booster shot to get regardless of which initial vaccine you received. Any booster will improve your disease protection.
- A National Institutes of Health study indicated it may be beneficial to get a Moderna or Pfizer booster, regardless of which initial vaccine you received
What’s a booster shot?
For some viruses, the protection we get from a vaccine starts to wear off over time. An additional dose of the vaccine may be needed to boost your immune response and make sure you’re protected. Boosters are common for many vaccines, like Tdap (tetanus, diphtheria, and pertussis).
Can I get my COVID-19 booster and flu shot at the same time?
YES, it’s safe to do so and encouraged. If you’re eligible for your COVID-19 booster, you get your flu shot on the same day. If you’re not eligible for a COVID-19 booster yet, be sure to protect yourself from the flu and get your flu shot today.
Where can you get a booster?
You can get your booster anywhere COVID-19 vaccines are being offered.
Bring your vaccine card with you to the vaccine clinic/site. If you do not have your vaccine card, you can request one from your previous vaccinator or request your vaccination record through izrecord.nv.gov to bring with you. Upon arrival, your vaccinator may require you to complete a form self-verifying your eligibility.
How will I react to my booster?
So far, reactions reported after a booster were like that of the two-dose series: fatigue and pain at injection site were most common and most symptoms were mild to moderate.